Literature DB >> 16157619

Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains.

Mandy Wootton1, Peter M Bennett, Alasdair P MacGowan, Timothy R Walsh.   

Abstract

OBJECTIVES: To assess a link between resistance to Triton X-100 induced autolysis (TIA) and lowered atl expression in a collection of clinical glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA (hGISA).
METHODS: Nine clinical GISA, 11 hGISA and 11 glycopeptide-susceptible S. aureus (GSSA), including three pairs of related isolates, were analysed using TIA assays. Lysostaphin MICs were determined by a broth microdilution technique and reverse transcriptase PCR was used to compare atl expression levels in all isolates.
RESULTS: Eight of nine clinical GISA and six of 11 hGISA exhibited lower susceptibility to TIA and higher MICs of lysostaphin than GSSA. Eight of nine GISA and all hGISA strains had lowered atl expression levels compared with GSSA.
CONCLUSIONS: The majority of GISA and hGISA isolates exhibited lowered susceptibility to TIA and lysostaphin and reduced atl expression when compared with GSSA isolates. These factors could contribute to, or predispose to the development of, a thickened cell wall and glycopeptide-intermediate resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16157619     DOI: 10.1093/jac/dki289

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Christine Barras; Patrice François; Yvan Charbonnier; Elzbieta Huggler; Christian Garzoni; William L Kelley; Paul Majcherczyk; Jacques Schrenzel; Daniel P Lew; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Antibacterial fatty acids destabilize hydrophobic and multicellular aggregates of biofilm in S. aureus.

Authors:  Zulfiqar Ali Mirani; Shagufta Naz; Fouzia Khan; Mubashir Aziz; Muhammad Naseem Khan; Seema Ismat Khan
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

3.  Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.

Authors:  Klaudia Kosowska-Shick; Lois M Ednie; Pamela McGhee; Kathy Smith; Cynthia D Todd; Amanda Wehler; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

4.  In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.

Authors:  N McCallum; H Karauzum; R Getzmann; M Bischoff; P Majcherczyk; B Berger-Bächi; R Landmann
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

5.  "Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.

Authors:  Michie Saito; Yuki Katayama; Tomomi Hishinuma; Akira Iwamoto; Yoshifumi Aiba; Kyoko Kuwahara-Arai; Longzhu Cui; Miki Matsuo; Nanae Aritaka; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

6.  Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50.

Authors:  Sugunya Utaida; Richard F Pfeltz; R K Jayaswal; B J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins.

Authors:  Agnieszka Luczak-Kadlubowska; Jolanta Krzyszton-Russjan; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

8.  Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.

Authors:  Anne Yusof; Anette Engelhardt; Asa Karlsson; Lina Bylund; Pamela Vidh; Karen Mills; Mandy Wootton; Timothy R Walsh
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

9.  Transcriptional and functional analysis of the effects of magnolol: inhibition of autolysis and biofilms in Staphylococcus aureus.

Authors:  Dacheng Wang; Qi Jin; Hua Xiang; Wei Wang; Na Guo; Kaiyu Zhang; Xudong Tang; Rizeng Meng; Haihua Feng; Lihui Liu; Xiaohong Wang; Junchao Liang; Fengge Shen; Mingxun Xing; Xuming Deng; Lu Yu
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

10.  The beta-lactam-resistance modifier (-)-epicatechin gallate alters the architecture of the cell wall of Staphylococcus aureus.

Authors:  Paul D Stapleton; Saroj Shah; Kerstin Ehlert; Yukihiko Hara; Peter W Taylor
Journal:  Microbiology (Reading)       Date:  2007-07       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.